CNXC Stock Forecast & Price Target

Concentrix is supported by a resilient, diversified services model that continued to deliver $2.462 billion of fiscal Q2/26 revenue, up 2% year over year and broadly in line with expectations, while non-GAAP EPS of $2.63 matched forecasts and free cash flow rose 16% year over year to $209.7 million. Although healthcare fell 14% and technology and consumer electronics declined 6%, stronger growth in BFSI at 13% and retail, travel, and ecommerce at 10% helped offset weakness, and the company’s AI-enabled intelligent transformation offering across more than 2,000 organizations positions it to capture demand even as some verticals remain uneven. The bullish case is further reinforced by $257.9 million of operating cash flow, a manageable 3.0x net debt to TTM adjusted EBITDA, and the ability to fund $175 million of fiscal 2026 restructuring charges while still maintaining shareholder returns through the $0.36 quarterly dividend.

Concentrix is facing a deteriorating fundamental profile because Q2 revenue grew only 0.6% year-over-year in constant currency, full-year constant-currency growth guidance was cut to roughly 0.75% from about 2.5%, and management now expects growth to decelerate through the year as accelerated offshoring and client-spend pullbacks create a low-visibility, secular headwind. Although iX is gaining meaningful traction with deal count up about 400% year-over-year, nearly 100 signings in Q2, and annual recurring revenue on track to exceed $120M, that still sits on a roughly $10B revenue base and cannot yet offset the roughly 3% offshoring drag, plus additional pressure from healthcare and certain cloud, social, and telecom clients. Even with adjusted Q2 FCF of about $242M, net debt down to roughly $4.32B, and reaffirmed second-half operating margins near 12.5%, the company’s dependence on offshore delivery, acquisition-led growth, and a crowded AI customer-experience market leaves the long-term setup uncertain and supports a negative outlook.